Homology Medicines Current Ratio 2017-2019 | FIXX

Homology Medicines current ratio from 2017 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Homology Medicines Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.19B $0.02B 10.80
2018-12-31 $0.22B $0.02B 9.84
2018-09-30 $0.25B $0.02B 13.24
2018-06-30 $0.26B $0.01B 24.05
2018-03-31 $0.12B $0.01B 12.75
2017-12-31 $0.13B $0.01B 14.85
2017-09-30 $0.00B $0.00B 0.00
2017-06-30 $0.00B $0.00B 0.00
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.01B $0.01B 1.88
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.809B $0.004B
Homology Medicines Inc. is a genetic medicines company. Its platform offers human hematopoietic stem cell derived adeno-associated virus vectors to treat disease-causing mutations through gene correction, insertion and knockout. Homology Medicines Inc. is based in BEDFORD MA.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $37.999B 6.92
Mylan (MYL) United Kingdom $8.773B 3.83
Teva Pharmaceutical Industries (TEVA) Israel $8.379B 3.28
Bausch Health Cos (BHC) Canada $7.555B 5.16
Dr Reddy's Laboratories (RDY) India $6.155B 23.02
Supernus Pharmaceuticals (SUPN) United States $1.645B 16.44
Amphastar Pharmaceuticals (AMPH) United States $0.933B 52.16
Voyager Therapeutics (VYGR) United States $0.893B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.778B 1.16
Akorn (AKRX) United States $0.535B 0.00
CymaBay Therapeutics (CBAY) United States $0.431B 0.00
Assembly Biosciences (ASMB) United States $0.371B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.347B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.275B 0.00
Sol-Gel Technologies (SLGL) Israel $0.161B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.125B 0.00
Acasti Pharma (ACST) Canada $0.071B 0.00
Agile Therapeutics (AGRX) United States $0.058B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.054B 0.00
Teligent (TLGT) United States $0.030B 0.00
Evoke Pharma (EVOK) United States $0.015B 0.00
Aevi Genomic Medicine (GNMX) United States $0.011B 0.00